Fauci says 'prudent' to have Omicron vaccine, but may not be neededA COVID-19 vaccine specifically targeting the Omicron variant would be "prudent" even if it ultimately may not be needed, the top U.S. infe...
EU approves two sites for making Pfizer's COVID-19 vaccineMeanwhile, the European Union's medicines regulator has started evaluating the use of Pfizer Inc and BioNTech's COVID-19 vaccine in childre...
Moderna raises 2021 sales forecast for COVID-19 vaccine to $19.2 billionEarlier this week, larger rival Pfizer Inc said it expects $26 billion in sales of its COVID-19 vaccine this year.
Gold eases as vaccine roll out counters US stimulus optimismThe first shipments of COVID-19 vaccine began on Sunday, after a U.S. regulator approved Pfizer Inc and BioNTech SE 's vaccine.
COVID-19 vaccine could fundamentally change pandemic direction: WHOBruce Aylward also told the WHO's annual ministerial assembly that interim results announced earlier in the day from Pfizer Inc's phase-thr...
Lupin arm gets tentative FDA nod for anti-bacterial drugGavis has received tentative approval for its Azithromycin for oral suspension USP from the USFDA, Lupin said in a BSE filing.
Pfizer surges 5% as parent acquires Medivation in $14 bn dealThe US-based company said the acquisition would be immediately accretive to adjusted diluted EPS upon closing of the deal.
Drug firm Pfizer gets Bombay High Court nod for merger of Wyeth LtdIn November last year Pfizer and Wyeth had said they will merge their India operations under a single brand as part of efforts to boost bus...
- Pfizer completes sale of animal health biz for Rs 471.60 crore
Pfizer's animal health business has presence primarily in the large animal health and poultry market segments and also includes marketing s...
- Wyeth Q2 net down 11 pc at Rs 30.25 crore
Wyeth Ltd a subsidiary of global pharma major Pfizer Inc today said its net profit declined by 10.89 per cent to Rs 30.25 crore for the qua...
- Ranbaxy Laboratories launches generic Cadeut in the American market
Drug firm Ranbaxy Laboratories on Tuesday launched a generic version of Caduet, used for treating cardio vascular diseases, in the US marke...
- Orchid Chemicals settles case with Pfizer Inc; stock down
Hyderabad-based Orchid Chemicals has reached an out-of-court settlement with world’s largest drugmaker Pfizer Inc to sell a low-cost versio...
- Orchid Chemicals settles case with Pfizer Inc
Orchid Chemicals has reached an out-of-court settlement with world’s largest drugmaker Pfizer Inc to sell a low-cost version of the America...
- Ranbaxy reports loss in Q4, 2011 sales forecast flat
Ranbaxy Laboratories disappointed markets with a weak sales forecast, after it swung into loss in its fourth quarter ending its run of six ...
- Pfizer 3Q profit down 70 pc due to charges
Pfizer Inc said on Tuesday that revenue in the third quarter jumped 39 per cent, but hefty charges related to that $68 billion purchase dra...
- Pfizer to acquire 33.77% of its India unit
Pfizer Investments Netherlands BV on Monday said it will make a tender offer to acquire an additional 33.77% stake in Pfizer India from pub...
- Pfizer India evaluates impact of deal with J&J
Pfizer India, a subsidiary of the global pharmaceutical major Pfizer Inc, on Monday said it was evaluating the impact of the sale of global...